Difficult-to-manage axSpA

Recorded at #EULAR2025, Olivier chats with Jean-Guillaume Letarouilly and the Rheumavision winners about creativity, science communication, and what this experience meant to them.

Join Rudi and Pierre in the latest #EMEUNETPodcast as they shine a light on the emerging and fast-growing field ofcardio-rheumatology.

Renske chats with Cristiana Seiero Santos, Jean-Guillaume Letarouilly & Tue Kragstrup, the visionaries behind #Rheumavision.Learn about its foundation — and join the final event at #EULAR2025!

Join Gozde and Oliver as they talk with Prof. Denis Poddubnyy about the ASAS consensus definition of difficult-to-manage axSpA.Get a behind-the-scenes look at how this definition was developed, the challanged faced, and what it means for clinical practice and research.

Come along and join Barbara and Renske as they have a really great talk with Dr Nikiphorou about the connection between nutrition and RMDs, key research findings, and how all of this relates to the clinic.

Join Renske and Olivier as they test your knowledge of reproductive rheumatology in this special episode. They will be joined by Prof. Radboud Dolhain from Erasmus MC, Rotterdam, who will share his expertise on the subject!

Join Olivier and Pierre and hear from 3 winners of the EMEUNET Top 10 Abstracts! Listen to Jacob Koopman, Johannes Knitza and Andreas Kerschbaumer to find out more about their work and their experience of the ACR Convergence!

Join Barbara and Pierre and hear from Dr. Bryant England, Associate Professor of the University of Nebraska who investigates RA-ILD in the Veterans Affairs RA registry. Learn about his effort to use such valuable dataset to estimate risk of lung cancer in patients with RA-ILD, and more!

Join Krystel and Pierre and hear from 3 special guests! Mr. Peter Boyd (PARE), Dr. Sarah Bennett (HPR) and Dr. Jordi Anton (PAED) will discuss from various perspective why information to patients and shared- decision making is crucial in Rheumatology.

Join Claudia and Pierre and hear from Prof. Gaetane Nocturne about lymphoma in Sjogren’s disease. Learn about the different therapeutic options and how effective they may be. We will also keep up with recent advances in treatment of Sjogren’s disease!